The density of extracellular matrix proteins regulates inflammation and insulin signaling in adipocytes

FEBS Letters

Volumn 584, Issue 19, 2010, Pages 4145-4150

  Li, Qinkai ^a   Hata, Akiko ^a   Kosugi, Chisato ^a   Kataoka, Nananko ^a   Funaki, Makoto ^a,b  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adipocyte; Adiponectin; Extracellular matrix; Inflammation; Insulin sensitivity; Monocyte chemoattractant protein 1

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; COLLAGEN TYPE 1; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL STRAIN 3T3; CONTROLLED STUDY; COVALENT BOND; CYTOKINE RELEASE; IMMUNOREGULATION; INFLAMMATION; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CHEMOKINE CCL2; EXTRACELLULAR MATRIX PROTEINS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 77957165242     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.08.033     Document Type: Article

References (46)

1. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
2. Birk D., Cohen R., Geiger B., Goodenough D., Gumbiner B., Hynes R., Reichaedt L., Ruoslahti E., Trestad R., Walsh F., Yurchenco P. The Extracellular Matrix of Animals. The Molecular Biology of the Cell 1994, 14. Garland Publishing, Inc., New York. B. Alberts, A. Johnson, P. Walter, J. Le wis, M. Raff, K. Roberts (Eds.).
3. Juliano R.L., Haskill S. Signal transduction from the extracellular matrix. J. Cell Biol. 1993, 120:577-585.
4. Winer J.P., Janmey P.A., McCormick M.E., Funaki M. Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng. Part A 2009, 15:147-154.
5. Tee S.Y., Bausch A.R., Janmey P.A. The mechanical cell. Curr. Biol. 2009, 19:R745-R748.
6. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 1996, 12:697-715.
7. Khan T., et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell Biol. 2009, 29:1575-1591.
8. Bortell R., Owen T.A., Ignotz R., Stein G.S., Stein J.L. TGF beta 1 prevents the down-regulation of type I procollagen, fibronectin, and TGF beta 1 gene expression associated with 3T3-L1 pre-adipocyte differentiation. J. Cell Biochem. 1994, 54:256-263.
9. Liang X., et al. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E103-E113.
10. Weiner F.R., Shah A., Smith P.J., Rubin C.S., Zern M.A. Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha. Biochemistry 1989, 28:4094-4099.
11. Stupack D.G., Cheresh D.A. Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 2002, 115:3729-3738.
12. Li Q., Hosaka T., Jambaldorj B., Nakaya Y., Funaki M. Extracellular matrix with the rigidity of adipose tissue helps 3T3-L1 adipocytes maintain insulin responsiveness. J. Med. Invest. 2009, 56:142-149.
13. Yeung T., et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskeleton 2005, 60:24-34.
14. Funaki M., Randhawa P., Janmey P.A. Separation of insulin signaling into distinct GLUT4 translocation and activation steps. Mol. Cell Biol. 2004, 24:7567-7577.
15. Li Q., et al. NO-1886 suppresses diet-induced insulin resistance and cholesterol accumulation through STAT5-dependent upregulation of IGF1 and CYP7A1. J. Endocrinol. 2010, 204:47-56.
16. Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000, 11:327-332.
17. Arner P. Insulin resistance in type 2 diabetes-role of the adipokines. Curr. Mol. Med. 2005, 5:333-339.
18. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270:26746-26749.
19. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. CDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 1996, 221:286-289.
20. Saito K., et al. Organization of the gene for gelatin-binding protein (GBP28). Gene 1999, 229:67-73.
21. Ouchi N., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296-1301.
22. Arita Y., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
23. Tsao T.S., Tomas E., Murrey H.E., Hug C., Lee D.H., Ruderman N.B., Heuser J.E., Lodish H.F. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J. Biol. Chem. 2003, 278:50810-50817.
24. Kanda H., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116:1494-1505.
25. Ueda A., et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 1994, 153:2052-2063.
26. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 1995, 7:728-735.
27. Grimble R.F. Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5:551-559.
28. Halberg N., et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell Biol. 2009, 29:4467-4483.
29. Berria R., et al. Increased collagen content in insulin-resistant skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E560-E565.
30. Yamauchi T., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7:941-946.
31. Wu X., Motoshima H., Mahadev K., Stalker T.J., Scalia R., Goldstein B.J. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 2003, 52:1355-1363.
32. Guilherme A., Torres K., Czech M.P. Cross-talk between insulin receptor and integrin alpha5 beta1 signaling pathways. J. Biol. Chem. 1998, 273:22899-22903.
33. Barberis L., et al. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J. Biol. Chem. 2000, 275:36532-36540.
34. Begum N., Sandu O.A., Ito M., Lohmann S.M., Smolenski A. Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J. Biol. Chem. 2002, 277:6214-6222.
35. Lebrun P., Baron V., Hauck C.R., Schlaepfer D.D., Van Obberghen E. Cell adhesion and focal adhesion kinase regulate insulin receptor substrate-1 expression. J. Biol. Chem. 2000, 275:38371-38377.
36. Hu X., She M., Hou H., Li Q., Shen Q., Luo Y., Yin W. Adiponectin decreases plasma glucose and improves insulin sensitivity in diabetic Swine. Acta Biochim. Biophys. Sin. (Shanghai) 2007, 39:131-136.
37. Matsuda M., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 2002, 277:37487-37491.
38. Zoico E., et al. The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-kappaB pathway. Int. J. Mol. Med. 2009, 24:847-851.
39. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001, 507:142-146.
40. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2002, 290:1084-1089.
41. Long Q., et al. Peroxisome proliferator-activated receptor-gamma increases adiponectin secretion via transcriptional repression of endoplasmic reticulum chaperone protein ERp44. Endocrinology 2010, 151:3195-3203.
42. Kim Chung le T., Hosaka T., Yoshida M., Harada N., Sakaue H., Sakai T., Nakaya Y. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression. Biochem. Biophys. Res. Commun. 2009, 390:613-618.
43. Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 1996, 120:803-812.
44. Kim C.S., et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. (Lond.) 2006, 30:1347-1355.
45. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2003, 100:7265-7270.
46. Mariman E.C., Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell. Mol. Life Sci. 2010, 67:1277-1292.